Recent Antimicrobial Susceptibilities for Uropathogenic Escherichia coli in Patients with Community Acquired Urinary Tract Infections: A Multicenter Study
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to determine the prevalence and disease-specific antimicrobial susceptibility of Escherichia coli in urinary tract infections (UTIs).Materials and Methods: A total of 862 patients older than 18 years of age, who were diagnosed with UTI between January 2013 and December 2015, were included. The results of urine culture, prevalence of extended-spectrum beta lactamase (ESBL)-producing E. coli, and antimicrobial susceptibility by disease were also examined. Results: A total of 862 uropathogens were isolated. Among then, E. coli accounted for 756 (87.7%) isolates. The susceptibility rates of E. coli to the following antimicrobial agents were as follows: ampicillin 29.4%, cefazolin 70.5%, ceftazidime 75.1%, cefotaxime 75.0%, cefepime 76.2%, cefoxitin 88.8%, amoxicillin-clavulanic acid 63.6%, trimethoprim-sulfamethoxazole 60.6%, gentamicin 71.4%, ciprofloxacin 73.0%, piperacillin/tazobactam 93.9%, amikacin 99.2%, imipenem 99.1%, and ertapenem 99.3%. The frequency of ESBL-producing E. coli strains was 24.6%. The antimicrobial susceptibility of UTI varied by each disease, but without statistical significance.Conclusions: It is necessary to regularly examine the disease-specific resistance rates to determine the appropriate empiric antibiotic treatment, and the national antibiotic usage policies must be reorganized according to the data obtained from these studies.
Abstract
Purpose: The aim of this study was to determine the prevalence and disease-specific antimicrobial susceptibility of Escherichia coli in urinary tract infections (UTIs).Materials and Methods: A total of 862 patients older than 18 years of age, who were diagnosed with UTI between January 2013 and December 2015, were included. The results of urine culture, prevalence of extended-spectrum beta lactamase (ESBL)-producing E. coli, and antimicrobial susceptibility by disease were also examined. Results: A total of 862 uropathogens were isolated. Among then, E. coli accounted for 756 (87.7%) isolates. The susceptibility rates of E. coli to the following antimicrobial agents were as follows: ampicillin 29.4%, cefazolin 70.5%, ceftazidime 75.1%, cefotaxime 75.0%, cefepime 76.2%, cefoxitin 88.8%, amoxicillin-clavulanic acid 63.6%, trimethoprim-sulfamethoxazole 60.6%, gentamicin 71.4%, ciprofloxacin 73.0%, piperacillin/tazobactam 93.9%, amikacin 99.2%, imipenem 99.1%, and ertapenem 99.3%. The frequency of ESBL-producing E. coli strains was 24.6%. The antimicrobial susceptibility of UTI varied by each disease, but without statistical significance.Conclusions: It is necessary to regularly examine the disease-specific resistance rates to determine the appropriate empiric antibiotic treatment, and the national antibiotic usage policies must be reorganized according to the data obtained from these studies.
참고문헌 (18)
- Ronald AR, "Urinary tract infection in adults: research priorities and strategies", Int J Antimicrob Agents, 17, pp.343~348 (2001)
- Hooton TM, "Diagnosis and treatment of uncomplicated urinary tract infection", Infect Dis Clin North Am, 11, pp.551~581 (1997)
- Dielubanza EJ, "Urinary tract infections in women", Med Clin North Am, 95, pp.27~41 (2011)
- Flores-Mireles AL, "Urinary tract infections: epidemiology, mechanisms of infection and treatment options", Nat Rev Microbiol, 13, pp.269~284 (2015)
- Shah AA, "Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum betalactamases", Res Microbiol, 155, pp.409~421 (2004)
- De Backer D, "Evolution of bacterial susceptibility pattern of Escherichia coli in uncomplicated urinary tract infections in a country with high antibiotic consumption: a comparison of two surveys with a 10 year interval", J Antimicrob Chemother, 62, pp.364~368 (2008)
- Schito GC, "The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections", Int J Antimicrob Agents, 34, pp.407~413 (2009)
- Pitout JD, "Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment", Expert Rev Anti Infect Ther, 10, pp.1165~1176 (2012)
- Stamm WE, "Urinary tract infections: disease panorama and challenges", J Infect Dis, 183(Suppl 1), pp.S1~S4 (2001)
- Muratani T, "Bacterial resistance to antimicrobials in urinary isolates", Int J Antimicrob Agents, 24(Suppl 1), pp.S28~S31 (2004)
- 고영휘, "1979년과 2001년 요로감염증의 주요 원인균과 감수성의 변화에 관한 고찰", Investigative and Clinical Urology, 44(4), pp.342~350 (2003), 대한비뇨기과학회
- Kim ME, "Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006", Int J Antimicrob Agents, 31(Suppl 1), pp.S15~S18 (2008)
- Gupta K, "International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women:A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases", Clin Infect Dis, 52, pp.e103~e120 (2011)
- Goettsch W, "Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the Netherlands", J Antimicrob Chemother, 46, pp.223~228 (2000)
- Paterson DL, "Extended-spectrum beta-lactamases:a clinical update", Clin Microbiol Rev, 18, pp.657~686 (2005)
- Johnson DE, "Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice", Infect Immun, 66, pp.3059~3065 (1998)
- Johnson JR, "Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis", J Infect Dis, 191, pp.46~50 (2005)
- Johnson JR, "Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women", J Clin Microbiol, 43, pp.6064~6072 (2005)